Leonard Green & Partners’ Acquisition of a majority interest in MDVIP

Choate represented Summit Partners and its portfolio company, MDVIP, in the sale of a majority interest in MDVIP to private equity firm Leonard Green & Partners. MDVIP, the national leader in affordable personalized healthcare, today announced that Leonard Green & Partners, a leading private equity investment firm, has acquired a majority interest in the company […]

Tellurian and Bechtel Oil, Gas and Chemicals’ EPC Agreements Totaling $15.2B For Driftwood LNG

Vinson & Elkins advised Driftwood LNG LLC and Tellurian Inc. in connection with four fixed price, lump sum turnkey agreements between Tellurian and Bechtel Oil, Gas and Chemicals, Inc., totaling $15.2 billion, for the engineering, procurement and construction of Driftwood LNG, a liquefied natural gas export facility proposed near Lake Charles, Louisiana. Bechtel, a global […]

GraphPad Software, Inc.’s Recapitalization

Willkie represents Insight in its majority recapitalization of GraphPad Software, Inc., the premier provider of data analysis, statistics and graphing software solutions for scientific research applications. Insight Venture Partners finalized its majority recapitalization of GraphPad Software, Inc., the premier provider of data analysis, statistics and graphing software solutions for scientific research applications. Headquartered in La […]

Allegheny Technologies Incorporated’s $408 Million Registered Common Stock Offering

Cravath represented the underwriters, led by Goldman Sachs & Co. LLC, in connection with the $408 million registered common stock offering of Allegheny Technologies Incorporated Allegheny Technologies Incorporated produces and sells specialty materials and components worldwide. The company, led by Richard J. Harshman, Patrick J. DeCourcy, Kevin B. Kramer, John D. Sims and Robert S. […]

Bellwether Trial Win for Auxilium Pharmaceuticals

Arnold & Porter Kaye Scholer secured a victory on behalf of Auxilium Pharmaceuticals Inc., now a subsidiary of Endo Pharmaceuticals Inc., in the first bellwether trial case for its multidistrict litigation involving testosterone replacement therapy Testim. After a seven-day trial, a jury in the US District Court for the Northern District of Illinois determined that […]

Maxus Energy Corporation’s Chapter 11

Schulte represented the Official Committee of Unsecured Creditors (“Creditors’ Committee”) in the Chapter 11 cases of Maxus Energy Corporation and its affiliates In June 2016, Maxus filed for bankruptcy protection seeking court approval of a pre-bankruptcy settlement with its corporate parent YPF S.A. to release potentially billions-of-dollars of claims that Maxus and its affiliates had […]

PEG Africa’s $13.5 Million deal to expand reliable electricity access

Nixon Peabody LLP advised PEG Africa, the leading off-grid solar company in West Africa, in a USD $13.5M deal to expand reliable electricity access to the region’s unbanked consumers deemed risky by banks and microfinance. This recent round of fundraising will allow PEG Africa to provide direct loans and electricity to an additional half-million consumers […]

Sumitomo’s $211 Million Acquisition of Sawai American subsidiary

Debevoise & Plimpton LLP is advising Sawai Pharmaceutical, the parent company of Upsher-Smith Laboratories, in a new strategic alliance with Japanese trading house Sumitomo. Under the terms of the agreement, Sawai will sell a 20% stake in its American subsidiary to Sumitomo’s U.S. arm for $211 million. The transaction is expected to close near the […]

Warrior Met Coal’s $350 Million Senior Secured Notes Offering

Fried Frank acted as counsel to the initial purchasers in connection with Warrior Met Coal’s offering of US$350 million aggregate principal amount of 8.00% senior secured notes due 2024. Warrior Met Coal, Inc. engages in mining and exporting metallurgical coal for the steel industry. The company, led by Walter J. Scheller III, Jack K. Richardson […]

Westlake Chemical Corporation’ $500 Million Senior Notes Offering

Baker Botts advised Westlake Chemical Corporation on the transaction Westlake Chemical Corporation (NYSE: WLK) (“Westlake”) announced that it has priced an underwritten public offering of $500.0 million aggregate principal amount of senior unsecured notes due 2047 (the “Notes”) under its existing shelf registration statement. The Notes will bear interest at a rate of 4.375% per […]